Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Parameswar Dalai
Observed name:
Dalai, Parameswar
Institution:
National Institute of Pharmaceutical Education and Research - Ahmedabad
Observed institutions:
Indian Institute of Advanced Research,
National Institute of Pharmaceutical Education and Research - Ahmedabad
ORCID:
0009-0003-6570-9037
Observed ORCID:
0009-0003-6570-9037
OpenAlex ID:
A5078825418
Metabolic crosstalk: Extracellular ATP and the tumor microenvironment in cancer progression and therapy
2024
·
Sourav Shukla
, Parameswar Dalai
, et al.
·
Cellular Signalling
·
39
Antagonists of CD39 and CD73 potentiate doxycycline repositioning to induce a potent antitumor immune response
2024
·
Parameswar Dalai
, Dhruvi Shah
, et al.
·
Cellular Signalling
·
4
PDF
Caspase-1 inhibition by YVAD generates tregs pivoting IL-17 to IL-22 response in β-glucan induced airway inflammation
2022
·
Divyesh Patel
, Naveen Challagundla
, et al.
·
Immunopharmacology and Immunotoxicology
·
4
Doxycycline modulation of the CD39/CD73–adenosine axis to enhance CD8⁺ T cell and M1 macrophage immunity in patient-derived breast cancer samples.
2026
·
Parameswar Dalai
, Reena Agrawal Rajput
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
8
Citation count:
47
H-index:
3
I10-index:
1
Year
Topic
Type